Thromboembolic risk rises without anticoagulants after cardioversion

07/19/2013 | Healio

A 5,116-participant study found that patients who are at risk of thromboembolism are more likely to suffer thromboembolic events if they are not treated with anticoagulants following cardioversion of acute atrial fibrillation. The results affirm the European Society of Cardiology's 2010 recommendation that acute AF patients receive anticoagulants, specifically heparin peri-cardioversion followed by long-term use of a vitamin K antagonist during and after restoration of normal heart rhythm.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC